-
Co-Investment
WCG
USA
Healthcare & life scienceExited
Healthcare & life scienceWIRB is the largest US « IRBs » (Institutional Review Boards), which are federally mandated to approve ethical issues in research protocols involving human subjects.
-
Co-Investment
Kangji Medical
China
Internet Software & ServicesInternet Software & ServicesKangji Medical is a leading Chinese medical device and consumable manufacturer with focus in abdominal minimally invasive surgery. The company offers a comprehensive portfolio of reusable and disposable instruments for laparoscopy, thoracoscopy, gynecology, urology, gastroenterology and ENT specialties.
-
Buyout
Dedalus
Italy
Technology, Media and TelecomTechnology, Media and TelecomDedalus is a global healthcare software company and one of the largest in the world, offering leading solutions covering the entire spectrum of the continuum of care, helping the healthcare organizations to deliver new models of care. Today the company supports over 6,300 healthcare organizations and 5,700 labs and diagnostic centers, and its software is used widely across the world, managing each year more than 3 billion diagnostic results, serving 540 million population, 28 million Inpatient and 35 million emergency admissions, while in primary care, serve more than 120 million citizens. Today, the group employs more than 6,600 highly skilled qualified people and has the largest software R&D team in the industry in Europe (∼40% of workforce).
Deal team
Press releases
-
Expansion
Ionisos
France
Healthcare & life scienceExited
Healthcare & life scienceIonisos is a specialist in ionising radiation sterilisation and was created through the 1993 merger of Conservatome and Amphytrion. Ionisos is the leading cold sterilisation service provider in France and Spain. It is the only group in France that provides all three cold sterilisation technologies: gamma radiation, beta radiation and ethylene oxide. The company employs about one hundred staff across its seven sites in France and Spain.
Deal team
Press releases
-
Buyout
Envision Pharma
United-KIngdom
Healthcare & life scienceExited
Healthcare & life scienceEnvision Pharma is an international, innovative global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies. Envision currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies. Envision currently has ten offices, three in the United Kingdom, five in the United States, two in Asia Pacific, and employs around 450 team members.
-
Buyout
Trigo
France
Business servicesBusiness servicesFounded in 1997, TRIGO is a multinational company providing quality management solutions for the manufacturing sector, particularly within the transportation industries. With annual revenues of +300 M€ and a team of more than 9,000 professionals present in 20 countries, TRIGO offers a comprehensive portfolio of Quality Management and Inspection Services to the leading international manufacturers of the automotive, aerospace and heavy transportation industries.
Deal team
Press releases
- Trigo, supported by Ardian, acquires French specialist Euro-Symbiose
- Francis Niss appointed as new chairman of the supervisory board of Trigo
- Trigo to join forces with Böllinger in Germany with Ardian's support
- Ardian enters into exclusive negotiations to acquire Trigo Group from IK investments partners